Skip to content
Unrated Drug recall · FDA · Published December 20, 2017

Kamins Day Cream SPF15 Recalled for Stability Failure

Kamins Dermatologics recalls 21 jars of Day Cream SPF15 due to failed stability specifications. Check lot J146C and expiration date.

🇺🇸 FDA recall #D-0231-2018DrugKamins Dermatologics ›
Take action

Contact the company

Recalling firmOdan Laboratories Ltd325 Stillview Ave · Pointe-Claire, Canada
✎ GovInfoNow plain-language explainer

What happened, in plain English

Kamins Dermatologics Inc. is recalling 21 jars of Day Cream SPF15 because the product failed stability specifications under long-term room temperature conditions. The affected item was distributed nationwide in the USA. No specific remedy or injury details are provided in the record. Read more at govinfonow.com/recall/41006-kamins-day-cream-spf15-recalled-for-stability-failure.

Source Summary by GovInfoNow · govinfonow.com/recall/41006-kamins-day-cream-spf15-recalled-for-stability-failure · Updated October 11, 2026 · FDA enforcement record: FDA #D-0231-2018

Cite this page

“Kamins Day Cream SPF15 Recalled for Stability Failure.” GovInfoNow, updated October 11, 2026. https://govinfonow.com/recall/41006-kamins-day-cream-spf15-recalled-for-stability-failure. Based on FDA recall #D-0231-2018 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0231-2018%22&limit=1).

Why it’s dangerous

The recall was initiated because the cream failed stability specifications at 12 months under long-term room temperature conditions. The record does not specify what chemical changes or safety risks result from this failure.

Who’s affected

Consumers who purchased the specific lot of Day Cream SPF15 distributed nationwide in the USA. It is unclear if any injuries have occurred as the hazard mechanism is not described.

How to tell if you have this one

Look for a 15 ml / 0.5 fl. oz jar of Day Cream SPF15 Crème de jour FPS 15 containing Avobenzone 2%, Octinoxate 7%, and Oxybenzone 5%. Check for UPC code 6 26354 10955 0, Lot # J146C, and an expiration date of 02-2019.

  • Brand
    Kamins Dermatologics
  • Product
    Day Cream SPF15 Cr¿me de jour FPS 15, { Avobenzone 2%, Octinoxate 7%, Oxybenzone 5%} 15 ml / 0.5 fl. oz jar. Made in
  • Category
    Drug
FDA recall event · 2 products

All 2 products in this recall

FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.

  • Classification
    Class II
  • Status
    Terminated
  • Distribution
    distributed nationwide in the USA
Recall numberProduct, codes & lotsQuantity
D-0231-2018Day Cream SPF15 Cr¿me de jour FPS 15, { Avobenzone 2%, Octinoxate 7%, Oxybenzone 5%} 15 ml / 0.5 fl. oz jar. Made in Canada, Kamins Dermatologics Inc. Montreal, Quebec H9R 2Y6. Distributed by Kamins Dermatologics Montreal, Quebec H9R 2Y6 Made in Fabrique au Canada. UPC code 6 26354 10955 0; Lot # J146C, EXP 02-2019.21 jars
D-0232-2018Dry to Normal Skin Starter Kit, Trousse debutante pour peau seche a normale. Kit includes: (Vegetable Cleanser (60 ml / 2 oz), Night Cream (15 g / 0.5 oz), Day Cream SPF15 {Octinoxate 7%, Avobenzone 2% and Oxybenzone 5%} (15 g / 0.5 oz), Eye Cream (6 g / 0.21 oz).Made in Canada, Kamins Dermatologics Inc. Montreal, Quebec H9R 2Y6. Distributed by Kamins Dermatologics (USA) Inc. 99 Hudson, New York, NY, USA. UPC code 6 06354 61322 4; Lots # J203, J204, EXP 02-2018; J228, J274, EXP 09-2018179 kits

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “distributed nationwide in the USA” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 6 months after the firm started it.

1. Firm started the recall: Dec 20, 201712. FDA classified it Class II: Jan 24, 201823. Published in FDA’s Enforcement Report: Jan 31, 201834. FDA terminated the recall: Jun 18, 2018420172018
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0231-2018 (December 20, 2017) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0231-2018 to see it in context.
  • Plain-language summary written by qwen3.6:35b-a3b on October 11, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA